Yu. G. Payanidi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Ovarian cancer (OC) is among the leading causes of cancer-related mortality in women. A high risk of OC (lifetime estimates ranging 10–60%) is determined by BRCA1/2 mutations. The 1100delC variant of CHEK2 is associated with predisposition to breast cancer (BC) in women. With the known spectrum and frequencies of mutations of these genes, it is possible to(More)
  • 1